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Results of the cardiac surgery programmed among patients having a
morbid obesity (IMC>40)
Laurent Guesnier
CH Lens, Chirurgie cardiaque de l'artois, Lens, France
Objectives: The increasing proportion of obese patients candidates for a
cardiac surgery obliges us to reflect on the périopératoire risk this population
in order to direct with better our assumption of responsibility. 
We studied the results of the cardiac surgery for the obese patients pre-
senting an index of body mass (IMC) >40.
Methods: Retrospective study on a prospective basis of data of
3564 patients operated in surgery programmed between 2004 and 2012. The
population was divided into three groups: I (n=2494): 20 <IMC <29,9; II
(n=1014): 30 < IMC < 39,9 and III (n=56): IMC ≥40. The IMC < 20 were
excluded because of a surmortality brought back in the literature. The prin-
cipal criterion of judgement was mortality at 90 days. An analysis of multi-
variate regression was carried out in order to identify the prognostic factors of
mortality. A comparative study of the principal postoperative complications
was carried out.
Results: Mortality at 90 days was 4,1% in group I, 3,7% in group II and
of 0% in group III (p NS). In group III, the average age was younger:
57,2±8,2 years vs 68,4±10,7 years (group I) and 64,9±9,8 (group II) (p<0,05).
58,2% and 27,7% of the patients had respectively a coronary or valvular sur-
gery isolated, 9,7% a valvular and coronary combined surgery and 4,4% a dif-
ferent gesture. The rates of parietal surgical recoveries or médiastinites were
comparable (group I: 2,6% N = 64; group II: 5,3% N = 54; group III: 5,4%
N=3) (p NS). In multivariate analysis, the factors influencing mortality were
the age > 60 years and the transfusion of globular bases. The BMI > 40 did
not influence mortality. 
Conclusion: Programmed cardiac surgery carried out among patients pre-
senting one IMC > 40 does not seem to be accompanied by an increase by
mortality and morbidity périopératoire. This population was younger in our
experiment, probably minimizing the postoperative rate of complications.
Despite everything, the IMC taken separately should not be a criterion of sur-
gical counter-indication.
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Mitral valve surgery complicated by circumflex artery: a rare but
serious complication
Grégoire Cauchois, Matthieu Godin, Fabien Doguet, Eric Durand, François
Bouchart, Christophe Tron, Jean-Paul Bessou, Hélène Eltchaninoff
CHU Charles Nicolle, Cardiologie, Rouen, France
Background: Circumflex coronary artery (CCA) injury during mitral valve
surgery is a rare but serious complication whit difficult diagnosis. The aim of
our study was to describe the elements of diagnosis that could allow preven-
tion of this complication.
Method and results: From 2006 to 2013 in Rouen University Hos-
pital, 8 patients (1.03%) among 775 undergoing mitral valve surgery
(repair or replacement) presented CCA occlusion confirmed by coronary
angiography. Sex ratio was 5 men for 3 women with a mean age of 54.2
years. Left main coronary dominance was present in 75%. Mitral valve
repair was performed in 5 patients and valve replacement in 3. The diag-
nosis was suspected by ECG in 7/8 patients: 6 patients (75%) presented
ST segment elevation, 1 had permanent AV block while EKG was normal
in one. CCA occlusion led to a significant impairment of left ventricular
function, median LVEF: decreased from 58 to 43% (p=0.04) although
coronary angiography was performed within one hour in 5 patients
(62.5%). Five had complete revascularization (4 of those with immediate
coronary angiography), while 3 were treated medically. Occlusion,
assessed by coronary angiography, was preferentially located on the
superolateral quarter of the mitral annulus next to the anterolateral com-
missure predominantly on its mid portion (75%). As regards to the mech-
anism of CCA occlusion, 37.5% of patients had a stitch passing through
the CCA, 50% had a kinking of the vessel due to a stitch located close to
the CCA and one of them had a compressive hematoma. Follow-up at
day-7 was uneventful in 7 patients with one in-hospital death one day
after the surgery (cardiac tamponade).
Conclusion: CCA injury is a rare but serious complication of mitral valve
surgery suspected on ECG, due to a stitch always located at the same point of
mitral annulus. An eventual intraoperative angiography in hybrid rooms could
be a specific solution for patients at risk (large mitral ring, left main coronary
dominance).
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One-year survival among patients supported with a ventricular assist
device: results of the hospital of Montpellier about 29 implantations
Philippe Gaudart (1), Pascal Battistella (2), Nordine Zeroual (1), Marc
Mourad (1), Francois Roubille (3), Philippe Rouvière (2)
(1) CHU Arnaud de Villeneuve, Anesthésie réanimation, Montpellier,
France – (2) CHU Arnaud de Villeneuve, Chirurgie cardiaque, Montpel-
lier, France – (3) CHU Arnaud de Villeneuve, Cardiologie, Montpellier,
France
Ventricular assist devices (VADs) are used to bridge the patient with end-
stage heart failure to cardiac transplantation (BTT) or to destination therapy
(DT).
Since 2003 in the Montpellier's hospital, 29 VADs have been implanted
(8 to DT). In the majority of cases, the VAD was used in acute end-stage of
heart failure; one-year mortality was 45%.
Unlike inotropic agents, levosimendan, a new calcium senziter, enhances
myocardial contractility without increasing myocardial oxygen consumption.
15 out of 29 patients were on the Intermacs classification level 1, on a
scale of 1 to 7, 9 received levosimendan and 6 did not.
9 of 29 patients were undergoing to levosimendan infusion to prevent right
ventricular failure; 5 were under mechanical ventilation and 5 under Extra-
corporal membran oxygenation (ECMO) or trans-aortic left ventricular dis-
charge by Impella 5.0 (Abiomed) before LVAD. 7 out of 29 patients (77.8%)
were alive one year later, among who one died from cancer. 2 patients were
under ECMO after LVAD.
In contrast, only 6 patients out of 29 patients (20,7%) without levosi-
mendan are alive after one year.
Multivariate analysis demonstrated a significant independant effect of levo-
simendan infusion on one year mortality in this retrospective study. 
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Prognosis impact of ventricular dysfunction in patients with acute
coronary syndrome undergoing surgical revascularization
Batric Popovic (1), Pablo Maureira (2), Nelly Agrinier (3), Ronan Debal-
lon (1), Fabrice Vanhuyse (2), Etienne Aliot (1), Jean Pierre Villemot (2)
(1) CHU Nancy Brabois, Cardiologie, Vandoeuvre Les Nancy, France –
(2) CHU Nancy Brabois, Chirurgie cardiovasculaire, Vandoeuvre Les
Nancy, France – (3) CHU Nancy, Epidémiologie et Evaluation clinique,
Nancy, France 
Background: Patients with non-ST elevation acute coronary syndrome
complicated by left ventricular dysfunction are a poor prognosis. The aims of
our study were to describe the use of surgical revascularization in these high
risk patients and to assess the impact of left ventricular dysfunction on long
term outcomes. 
Methods: Between 1996 and 2008, we performed elective, isolated, pri-
mary CABG in 206 consecutive patients with LVEF≤0.40 complicating acute
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